サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1362910

分岐部病変の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年

Bifurcation Lesions Market Size, Share & Trends Analysis Report By Application (Coronary Vascular, Peripheral Vascular), By Region (North America, Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 90 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
分岐部病変の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月06日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

分岐部病変市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の分岐部病変市場規模は2030年までに34億8,000万米ドルに達し、予測期間中のCAGRは5.9％を記録すると予測されています。

技術開発と償還に対する政府の支援策が、予測期間中の市場を牽引すると思われます。

高齢者人口の増加と不健康なライフスタイルは、心血管障害の発生率増加の原因となっています。さらに、革新的な機器の承認・商品化の増加や、今後数年間で分岐部病変の治療のための新しい機器の参入が見込まれることも、市場を牽引する可能性が高いです。

さらに、手頃な価格の上昇、低侵襲手術の需要の増加、医療ツーリズムの増加などの要因も、世界中で分岐部病変手術の需要を押し上げています。様々な調査によると、冠動脈分岐部病変に対する処置は経皮的冠動脈インターベンション全体の約20%を占めています。

分岐部病変市場レポートハイライト

  • 分岐部病変用デバイスの商品化の増加や業界各社による研究開発への投資が市場を押し上げる要因となっており、2023年から2030年までのCAGRは約5.9%と予想されます。
  • 冠動脈血管セグメントは、心臓内の複雑な血管網の存在、デバイスの入手可能性の増加、分岐部病変に対する外科的介入に関する意識の高まりにより、2022年の市場シェアで最大を占めました。
  • 末梢血管セグメントは、末梢アプリケーション用デバイス開発のための業界プレイヤーの投資増加や、プラークの正確な検出を容易にする診断の進歩により、今後数年間で有利な成長を示す可能性が高いです。
  • 地域別では、北米が2022年の分岐部病変市場で最大のシェアを占めました。薬剤溶出ステント需要の増加、分岐部病変用デバイスの商品化、主要市場プレイヤーの現地プレゼンスなどにより、今後も優位性を維持すると予測されます。
  • アジア太平洋地域は、医療インフラの改善、医療ツーリズム、同地域の市場プレイヤーによる投資の増加により、今後10年間で最も急速な成長が見込まれています。
  • Tryton Medical, Inc.は、バルーン拡張可能なTryton Side Branch Stentを開発し、分岐部病変の治療のために側枝動脈に留置することができます。このステントは米国、欧州、中東・アフリカで販売されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 分岐部病変の市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 分岐部病変市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 分岐部病変：用途の推定・動向分析

  • 分岐部病変市場：重要なポイント
  • 分岐部病変市場：動向と市場シェア分析、2022年および2030年
  • 末梢血管
  • 冠血管

第5章 分岐部病変市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別の分岐部病変市場：マーケットプレースにおける重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Boston Scientific Corporation
    • Abbott
    • Cardinal Health
    • Medtronic
    • C. R. Bard, Inc.
    • Johnson and Johnson Services, Inc.
    • Spectranetics
    • Terumo Medical Corporation
    • Tryton Medical Inc.
図表

List of Tables

  • 1. List of Abbreviations
  • 2. North America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 3. North America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 4. U.S. bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 5. Canada bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 6. Europe bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 7. Europe bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 8. Germany bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 9. UK bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 10. France bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 11. Italy bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 12. Spain bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 13. Sweden bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 14. Norway bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 15. Denmark bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 16. Asia Pacific bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 17. Asia Pacific bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 18. China bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 19. Japan bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 20. India bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 21. Australia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 22. Thailand bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 23. South Korea bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 24. Latin America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 25. Latin America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 26. Brazil bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 27. Mexico bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 28. Argentina bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 29. Middle East and Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 30. Middle East and Africa bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 31. South Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 32. Saudi Arabia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 33. UAE bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 34. Kuwait bifurcation lesions market, by application, 2018 - 2030 (USD Million)

List of Figure

1. Market research process

2. Data triangulation techniques

3. Primary research pattern

4. Market research approaches

5. Value-chain-based sizing & forecasting

6. QFD modeling for market share assessment

7. Market formulation & validation

8. Bifurcation lesions: Market outlook

9. Bifurcation lesions: Competitive insights

10. Parent market outlook

11. Related/ancillary market outlook

12. Penetration and growth prospect mapping

13. Industry value chain analysis

14. Bifurcation lesions market driver impact

15. Bifurcation lesions market restraint impact

16. Bifurcation lesions market strategic initiatives analysis

17. Bifurcation lesions market: Application movement analysis

18. Bifurcation lesions market: Application outlook and key takeaways

19. Peripheral vascular market estimates and forecasts, 2018 - 2030 (USD Million)

20. Coronary vascular market estimates and forecasts, 2018 - 2030 (USD Million)

21. Global bifurcation lesions market: Regional movement analysis

22. Global bifurcation lesions market: Regional outlook and key takeaways

23. North America market estimates and forecasts, 2018 - 2030 (USD Million)

24. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

25. Canada market estimates and forecasts, 2018 - 2030 (USD Million)

26. Europe market estimates and forecasts, 2018 - 2030 (USD Million)

27. UK market estimates and forecasts, 2018 - 2030 (USD Million)

28. Germany market estimates and forecasts, 2018 - 2030 (USD Million)

29. France market estimates and forecasts, 2018 - 2030 (USD Million)

30. Italy market estimates and forecasts, 2018 - 2030 (USD Million)

31. Spain market estimates and forecasts, 2018 - 2030 (USD Million)

32. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)

33. Norway market estimates and forecasts, 2018 - 2030 (USD Million)

34. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

35. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)

36. Japan market estimates and forecasts, 2018 - 2030 (USD Million)

37. China market estimates and forecasts, 2018 - 2030 (USD Million)

38. India market estimates and forecasts, 2018 - 2030 (USD Million)

39. Australia market estimates and forecasts, 2018 - 2030 (USD Million)

40. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)

41. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)

42. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)

43. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)

44. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)

45. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)

46. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)

47. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)

48. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)

49. UAE market estimates and forecasts, 2018 - 2030 (USD Million)

50. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

目次
Product Code: GVR-1-68038-534-2

Bifurcation Lesions Market Growth & Trends:

The global bifurcation lesions market size is expected to reach USD 3.48 billion by 2030, registering a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc.. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

The increasing geriatric population and unhealthy lifestyle are responsible for growth in the incidence of cardiovascular disorders. Furthermore, an increase in approval & commercialization of innovative devices and the expected entry of new devices for the treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, factors such as rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Bifurcation Lesions Market Report Highlights:

  • Increase in the commercialization of devices for bifurcation lesions and investments by industry players for R&D are the factors expected to boost the market, resulting in an anticipated CAGR of around 5.9% from 2023 to 2030
  • The coronary vascular segment accounted for the maximum share of the market in 2022 due to the presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • The peripheral vascular segment is likely to witness lucrative growth in the coming years due to an increase in investments by industry players for the development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2022. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and the local presence of major market players.
  • The Asia Pacific is expected to observe the fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and a rise in investments by market players in the region.
  • Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed the Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Bifurcation Lesions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Bifurcation Lesions Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Bifurcation Lesions: Application Estimates & Trend Analysis

  • 4.1. Bifurcation Lesions Market: Key Takeaways
  • 4.2. Bifurcation Lesions Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Peripheral Vascular
    • 4.3.1. Peripheral vascular market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Coronary Vascular
    • 4.4.1. Coronary vascular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bifurcation Lesions Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Bifurcation Lesions Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Boston Scientific Corporation
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Abbott
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Cardinal Health
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. C. R. Bard, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Johnson and Johnson Services, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Spectranetics
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Terumo Medical Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Tryton Medical Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives